The effects of chronic bromocriptine treatment on behaviour and dopamine receptor binding in the rat striatum.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  European Journal of Pharmacology

• Publication date

  1985-11-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(85)90673-9PMID 3936723
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of chronic bromocriptine and l-Dopa on spiperone binding and apomorphine-induced stereotypy

  2004cited by this paper
• Chronic levodopa or pergolide administration induces down‐regulation of dopamine receptors in denervated striatum

  1984cited by this paper
• Dopamine receptors in the denervated striatum: further supersensitivity by chronic haloperidol treatment.

  1983cited by this paper
• Behavioural and biochemical changes following chronic administration of L-dopa to rats.

  1982cited by this paper
• Dopamine receptor stimulation and striatal kainic acid neurotoxicity

  1981cited by this paper
• Dopamine receptor changes following destruction of the nigrostriatal pathway: lack of a relationship to rotational behavior.

  1981cited by this paper
• Central monoamine synapses as sites of action for ergot drugs.

  1980cited by this paper
• Brain dopamine receptors.

  1980cited by this paper
• Behavioral evidence for supersensitivity after chronic bromocriptine administration

  1979cited by this paper
• NEUROCHEMICAL PARAMETERS IN THE HYPERRESPONSIVE PHASE AFTER A SINGLE DOSE OF NEUROLEPTICS TO MICE

  1979cited by this paper
• Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors.

  1979cited by this paper
• Bromocriptine‐induced behavioral hypersensitivity

  1978cited by this paper
• Subsensitivity of the rat striatal dopaminergic system after treatment with bromocriptine: effects on [3H]spiperone binding and dopamine-stimulated cyclic AMP formation

  1978cited by this paper
• Central dopaminergic receptor supersensitivity and its relevance to Parkinson's disease

  1977cited by this paper
• Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity.

  1977cited by this paper
• Central deopaminergic receptor supersensitivity and its relevance to Parkinson's disease.

  1977cited by this paper
• Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain.

  1977cited by this paper
• Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

  1971cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Classic animal models of Parkinson's disease: a historical perspective.

  2019cites this paper
• The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s Disease

  2013cites this paper
• Context-driven changes in L-DOPA-induced behaviours in the 6-OHDA lesioned rat.

  2011cites this paper
• TITLE : Interaction of Synuclein and inflammation in Dopaminergic Neurodegeneration PRINCIPAL INVESTIGATOR :

  2009cites this paper
• Motor complications in Parkinson's disease and the clinical significance of rotational behavior in the rat: have we wasted our time?

  2006cites this paper
• Lack of cross-sensitization between the locomotor-activating effects of bromocriptine and those of cocaine or heroin

  2005cites this paper
• Locomotor-activating effects of the D2 agonist bromocriptine show environment-specific sensitization following repeated injections

  2005cites this paper
• Analysis of the effect of (-)-BPAP, a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain.

  2003cites this paper
• Modulation of Brain Dopaminergic Neurotransmission in Alcohol-Preferring Rats by Alcohol and Opioids

  1999cites this paper
• Repeated co-administration of caffeine and bromocriptine prevents tolerance to the effects of caffeine in the turning behavior animal model.

  1999cites this paper
• Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.

  1999cites this paper
• Is striatal dopaminergic receptor imbalance responsible for levodopa‐induced dyskinesia?

  1995cites this paper
• Levodopa‐induced dyskinesia

  1990cites this paper
• [Dopanergic agonists and schizophrenia].

  1989cites this paper
• Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist.

  1989cites this paper
• Non-additivity of D2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action.

  1989cites this paper
• Dopamine Receptor Changes During Chronic Drug Administration

  1989cites this paper
• D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy.

  1988cites this paper
• Agonist and antagonist actions of lisuride on dopamine neurons: electrophysiological evidence.

  1988cites this paper
• Dopamine receptor changes in response to prolonged treatment with L-dopa.

  1986cites this paper
• Reserpine-induced up-regulation of dopamine D2 receptors in the rat striatum is enhanced by denervation but not by chronic receptor blockade.

  1986cites this paper